What is Pharmacovigilance?
79680
the pharmacological science relating to the detection, assessment, understanding and prevention of adverse effects, particularly long term and short term side effect, of medicines (Source: The Importance of Pharmacovigilance, WHO 2002).\n\nIt is gaining importance for doctors and scientists as the number of stories in the media of drug recalls increases.
232386
Pfizer\n\nhttp://www.pfizerch.com/default.aspx
347194
PLEASE do not trust ANYTHING you read here in regards to medical information.\n\nCall your pharmacist and talk to them about the side effects you are experiencing.  Your eyes are worth more then some answers you get on Yahoo Answers.
210257
The FDA is in charge of food safety/nutrition, and drug evaluation and research.  Food and drugs are consumable items and both are health related.
881681
Applied Therapeutics by Koda-Kimble is a case based pharmacy text.\nThere's also good old Pharmacotherapy by DiPiro which is the gold standard.
197854
Yes I have seen it. And I believe it.  The pharmaceutical companies should have better testing requirements for the medications that they make, and push on the general public.
693339
Well I am, I think our FDA need to be ready for it, other people in other countrys have reported death with it. Everyone one come in and out of the USA, so yes we all need to be worried or at least conserned.
346962
EXECUTIVE SUMMARY\n\nSafety of Long Term Penicillin and Penicillin Derivatives\n\nThe safety of penicillin and penicillin derivatives when administered either intramuscularly, intravenously, or orally for extended periods of time (beyond the usual duration of use) can be extrapolated from multiple published studies. A review of the medical literature reveals studies in which such drugs have been used therapeutically for extended treatment durations. This includes studies of the treatment of recurrent acute otitis media, endocarditis, salmonella infections, prophylaxis of at risk populations (asplenic children, young children with sickle cell disease, patients with prior rheumatic fever), and the long term treatment of certain types of Lyme disease. Although most of these studies focus primarily on efficacy, they do routinely contain general statements indicating the safety and tolerability of the treatment under study. A few studies mentioned the presence of isolated cases of rash, gastrointestinal events, but none of the studies report the occurrence of a serious adverse event.\n\nA review of the Adverse Event Reporting System (AERS) database as performed by an Office of Post-Marketing Drug Risk Assessment (OPDRA) special programmer revealed occasional cases of adverse events associated with the administration of long term penicillin therapy, however, these adverse events were consistent with the known adverse event profile of penicillin. OPDRA concluded that "no increase in or atypical adverse drug reactions were noted in the few cases involving long-term administration of oral or intramuscular penicillin G or V (all dosage forms)." This data is generated via isolated adverse event reports submitted to the FDA, and it may be difficult to determine the overall rates of adverse events in relation to treatment duration. A similar analysis is currently being performed by OPDRA for amoxicillin and Augmentin®.\n\nThere is a higher incidence of cholestatic or mixed cholestatic-hepatocellular patterns of liver injury associated with administration of Augmentin®. This has been demonstrated by several published case reports. 8, 12, 14, 17, 20, 22, 24, 27, 28 Fatalities are very rare (on the order of one in several million) and similar hepatotoxicity is not thought to occur with amoxicillin administration. A study by Garcia-Rodriguez identified specific sub-populations who might be at increased risk for hepatotoxicity.10 These groups include older patients, and patients on long term therapy. The overall risk is still very low but was noted to be significantly higher than for the comparison group receiving amoxicillin. The information from this study was submitted in a labeling supplement and resulted in the identification of these risk groups in the label.\n\nThese antibiotics have an extensive history of use, and the lack of any serious adverse events as reported in these studies support their reputation as safe drugs. Reassurance can be derived from the fact that no increase in serious adverse events has been reported in the literature despite broad usage. Clinicians should still be aware that, although quite unlikely, when using these drugs over extended period of time, the potential exists for slight increases in the rates of specific adverse events which are infrequent enough to have escaped detection. Although there is no data to suggest such an increase (except for Augmentin® and hepatotoxicity), adverse events could include increased liver function tests, serum sickness, interstitial nephritis, effects on anti-coagulant therapy, and neutropenia. \n\nDETAILED REVIEW OF DATAc. Amoxicillin (n= 627)\n\nNine studies were identified which examined long term amoxicillin prophylaxis (4 weeks - 6 months) in children with recurrent acute otitis media. 29-37 There were 488 patients who were treated with doses ranging from 20-40 mg/kg/day of amoxicillin. In total, there were 11 adverse event reported. Four patients were report
678300
Recent news coverage examined a case where a pharmacy technician inadvertently mixed a dialysis preparation with potassium chloride instead of sodium chloride.  Both the KCl and the NaCl were made by the same manufacturer and were sold in boxes that were extremely alike.  In this case, 2 patients died before before the error was noticed.  \n\nOther common errors:\nDosage miscalculation: misreading the symbol "u" for units, or misinterpretation of a decimal point resulting in a 10 fold dosage increase. \nDispensing wrong medication due to look-alike names: For example, Accutane/Accupril, Celebrex/Celexa/Celebryx, Losec/Lasix, Narcan/Norcuron, Zantac/Zyrtec, Lamictal/Lamisil, Taxol/Taxotere, Seroquel/Serozone, hydroxyzine/hydroxyquine, Cephlex/Keflex, etc, etc....\n\nThat said, all mistakes are preventable when the appropriate measures.  A prescription should always be double checked, from start to finish, by the pharmacist, or another technician (in certain areas, where the tech-check-tech program has been implemented).  In essence, with all this checking, a prescription is essentially done twice.  Also, keeping look-alike products stored in separate areas helps considerably.
616743
Try these free medical dictionary\nhttp://www.free-medical-dictionary.com/\nhttp://www.pharma-lexicon.com/index.php?page=searchmenu#dictionary
71830
Check out this article:\nhttp://healthcare.monster.com/pharm/articles/pharmsales/
763519
I would want it released, because it can help 99% of sufferers, but I would want a "black box" warning to be attached, qualifying this risk.\nThere are many medications out now that have a known risk of causing severe reactions, including death.  I wouldn't use it as first-line therapy; instead, I would use it as a last resort, if the patient fails other standard therapy regimens.\nThe final decision should lie in the hands of the patient and their educated physician.  How old is the patient?  How severe is there disease?  What is the end goal?  \nThere would have to be more sufficient data about the warning signs of the fatal reaction (might we be able to possibly stop the medication in time?  how soon does the reaction occur?).\nI wouldn't be anxious to prescribe it until it was on the market for several years, and I had a chance to review the data on it.
816634
Go on line to Web MD, then to pill identifier. You should be able to find it there.  If not call poison controll they will know what it is.  Hope this helps
909652
pharmacogenomics would be a good one.
799314
Check out www.webmd.com You can search their drug interactions page.  Or ask your pharmacists for a drug interaction sheet.  It will expain the drug and what you should take or not take with your particular drug.
1092213
Your doctor. After a doctor has prescribed the medication, he occasionally gets to see the patient again to see if the medication is making progress. He has a way to evaluate whether or not a drug is making plausible effect.\n\nThe pharmacists do not have this type of direct evaluating.
259028
i took pharmacology and it was interesting. It a course about different kinds of drugs. It discusses the affects, the symptoms and the classification of the drug.